Opportunities for Targeting the Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Receptor Pathway in Hypertension
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Opportunities for Targeting the Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Receptor Pathway in Hypertension
Authors
Keywords
Renin-angiotensin system, RAS, Angiotensin-(1-7), Angiotensin converting enzyme 2, Mas receptor, Hypertension
Journal
CURRENT HYPERTENSION REPORTS
Volume 15, Issue 1, Pages 31-38
Publisher
Springer Nature
Online
2012-12-05
DOI
10.1007/s11906-012-0324-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relative affinity of angiotensin peptides and novel ligands at AT1and AT2receptors
- (2015) Sanja Bosnyak et al. CLINICAL SCIENCE
- Chronic activation of endogenous angiotensin-converting enzyme 2 protects diabetic rats from cardiovascular autonomic dysfunction
- (2012) Tatiane M. Murça et al. EXPERIMENTAL PHYSIOLOGY
- AVE 0991, a non-peptide Mas-receptor agonist, facilitates penile erection
- (2012) Andrey C. da Costa Gonçalves et al. EXPERIMENTAL PHYSIOLOGY
- Angiotensin II type 2 receptor agonists – where should they be applied?
- (2012) Ulrike Muscha Steckelings et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effect of combination of renin inhibitor and Mas-receptor agonist in DOCA–salt-induced hypertension in rats
- (2012) Yogendra Singh et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Angiotensin-(1-7) receptor Mas is an essential modulator of extracellular matrix protein expression in the heart
- (2012) Elisandra Gava et al. REGULATORY PEPTIDES
- Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction
- (2012) Tatiane M. Murça et al. REGULATORY PEPTIDES
- The Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas receptor axis: A potential target for treating thrombotic diseases
- (2012) Rodrigo Fraga-Silva et al. THROMBOSIS AND HAEMOSTASIS
- An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect
- (2011) Rodrigo Araujo Fraga-Silva et al. Clinics
- Angiotensin type 2 receptor in hypertensive cardiovascular disease
- (2011) Carmine Savoia et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- An Oral Formulation of Angiotensin-(1-7) Produces Cardioprotective Effects in Infarcted and Isoproterenol-Treated Rats
- (2011) Fúlvia D. Marques et al. HYPERTENSION
- Applications of post-translational modifications of FoxO family proteins in biological functions
- (2011) Ying Zhao et al. Journal of Molecular Cell Biology
- The Effect of the Thioether-Bridged, Stabilized Angiotensin-(1–7) Analogue Cyclic Ang-(1–7) on Cardiac Remodeling and Endothelial Function in Rats with Myocardial Infarction
- (2011) Matej Durik et al. International Journal of Hypertension
- Tissue Renin-Angiotensin-Aldosterone Systems: Targets for Pharmacological Therapy
- (2010) Michael Bader Annual Review of Pharmacology and Toxicology
- Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status
- (2010) Terry KW Ma et al. BRITISH JOURNAL OF PHARMACOLOGY
- Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases
- (2010) Anderson J. Ferreira et al. EXPERIMENTAL PHYSIOLOGY
- Vascular Relaxation, Antihypertensive Effect, and Cardioprotection of a Novel Peptide Agonist of the Mas Receptor
- (2010) Silvia Quintão Savergnini et al. HYPERTENSION
- ACE2–angiotensin-(1–7)–Mas axis and oxidative stress in cardiovascular disease
- (2010) Luiza A Rabelo et al. HYPERTENSION RESEARCH
- Evidence for Angiotensin-converting Enzyme 2 as a Therapeutic Target for the Prevention of Pulmonary Hypertension
- (2009) Anderson J. Ferreira et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Therapeutic Implications of the Vasoprotective Axis of the Renin-Angiotensin System in Cardiovascular Diseases
- (2009) Anderson J. Ferreira et al. HYPERTENSION
- Angiotensin-(1-7) Prevents Cardiomyocyte Pathological Remodeling Through a Nitric Oxide/Guanosine 3′,5′-Cyclic Monophosphate–Dependent Pathway
- (2009) Enéas R.M. Gomes et al. HYPERTENSION
- Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart
- (2008) Chantal Mercure et al. CIRCULATION RESEARCH
- Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis
- (2008) Robson A. S. Santos et al. EXPERIMENTAL PHYSIOLOGY
- Endothelial Dysfunction and Elevated Blood Pressure in Mas Gene-Deleted Mice
- (2008) Ping Xu et al. HYPERTENSION
- Structure-Based Identification of Small-Molecule Angiotensin-Converting Enzyme 2 Activators as Novel Antihypertensive Agents
- (2008) José A. Hernández Prada et al. HYPERTENSION
- Discovery and Validation of Novel Peptide Agonists for G-protein-coupled Receptors
- (2008) Ronen Shemesh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Renin-angiotensin system revisited
- (2008) F. Fyhrquist et al. JOURNAL OF INTERNAL MEDICINE
- Angiotensin-(1-7) with Thioether Bridge: An Angiotensin-Converting Enzyme-Resistant, Potent Angiotensin-(1-7) Analog
- (2008) L. D. Kluskens et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The sweeter side of ACE2: Physiological evidence for a role in diabetes
- (2008) Sharell M. Bindom et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started